Boai NKY Medical Holdings Ltd. engages in the manufacturing of chemical raw materials and products. Its business includes fine chemicals and precision medicine. The fine chemicals business includes polyvinylpyrrolidone (PVP) series and related intermediates, vinyl methyl ether/maleic anhydride copolymer (PVM/MA, Oriz) and related intermediates, oral care related series. The precision medicine business includes early tumor screening with gene sequencing as the main technology platform, molecular diagnosis of women's diseases, and personalized medical services. The company was founded on March 13, 2003 and is headquartered in Jiaozuo, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company